LAGE-3 Antibodies

Santa Cruz Biotechnology provides a broad selection of LAGE-3 monoclonal antibodies for research applications. LAGE-3 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LAGE-3, or cancer/testis antigen 1B, plays a significant role in tumor immunology and is primarily expressed in various cancers, making it a critical target for cancer research. Its expression is limited to the testis and certain tumors, highlighting its potential as a biomarker for cancer diagnosis and therapy. Understanding LAGE-3 function can provide insights into tumor progression and immune response, paving the way for novel therapeutic strategies. LAGE-3 monoclonal antibodies enable precise detection and characterization of LAGE-3 expression patterns in different cancer types. Researchers can leverage LAGE-3 monoclonal antibodies to investigate potential therapeutic targets and biomarker development. Santa Cruz Biotechnology monoclonal antibodies support cancer researchers worldwide in their mission to advance our understanding of tumor biology and develop more effective treatments.